Manuscripts
Showing 1552 manuscripts.
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090
Citation
Scott Evans, Tzu-min Yeh, Ned Sacktor, David B. Clifford, David M. Simpson, Eric N. Miller, Ronald J. Ellis, Victor G. Valcour, Christina M. Marra, Linda L. Millar, Giovanni Schifitto. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007. 8: 437-46.Year
2007
Journal
HIV Clinical Trials
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application
Citation
Kim Keil, Jill S. Hochreiter, Robin DiFrancesco, Barry Zingman, Richard C. Reichman, Margaret A. Fischl, Barbara Gripshover, Gene D. Morse. Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic Drug Monitoring. 2007. 29: 103-9.Year
2007
Journal
Therapeutic Drug Monitoring
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers
Citation
Qing Ma, Alan Forrest, Susan L Rosenkranz, Michael F. Para, Kevin E. Yarasheski, Richard C. Reichman, Gene D. Morse. Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharmaceutics & Drug Disposition. 2007. 29: 91-101.Year
2007
Journal
Biopharmaceutics & Drug Disposition
A truvada hypersensitivity reaction simulating abacavir hypersensitivity
Citation
Peter T. Frame, Carl J. Fichtenbaum. A truvada hypersensitivity reaction simulating abacavir hypersensitivity. AIDS. 2007. 21: 2252-3.Year
2007
Journal
AIDS
The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]
Citation
Minhee Kang, Raymond T. Chung. The role of early viral decline in the treatment of hepatitis C in HIV-1 coinfected persons [Letter to the Editor]. Journal of Acquired Immune Deficiency Syndromes. 2007. 46: 371-3.Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
Nonparametric estimation of the mean function of a stochastic process with missing observations
Citation
Joan X. Hu, Stephen W. Lagakos. Nonparametric estimation of the mean function of a stochastic process with missing observations. Lifetime Data Analysis. 2007. 13: 51-73.Year
2007
Journal
Lifetime Data Analysis
Statistics in medicine--reporting of subgroup analyses in clinical trials
Citation
Rui Wang, Stephen W. Lagakos, J. H. Ware, Deborah L. Hunter, J. Drazen. Statistics in medicine--reporting of subgroup analyses in clinical trials. New England Journal of Medicine. 2007. 357: 2189-94.Year
2007
Journal
New England Journal of Medicine
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania
Citation
Habib O. Ramadhani, Nathan Thielman, Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, Humphrey J. Shao, Susan C. Morpeth, Jonathan D. McNeill, John F. Shao, John Alexander Bartlett, John A. Crump. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases. 2007. 45: 1492-8.Year
2007
Journal
Clinical Infectious Diseases
Antiretroviral therapy for HIV-1-infected children in Haiti
Citation
Erik George, Francine Noel, Rose May Gyrlande Bois, Rachelle Cassagnol, Louise Estavien, Patricia De Matteis Rouzier, Rose I. Verdier, Warren D. Johnson, Jean William Pape, Daniel W. Fitzgerald, Peter Farnum Wright. Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases. 2007. 195: 1411-8.Year
2007
Journal
Journal of Infectious Diseases
Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2
Citation
Nicholas T. Funderburg, Michael M. Lederman, Zhimin Feng, Michael G. Drage, Julie Jadlowsky, Clifford V. Harding, Scott F. Sieg. Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America. 2007. 104: 18631-5.Year
2007
Journal
Proceedings of the National Academy of Sciences of the United States of America